Trial Information

Summary: Feasibility Evaluation of a Modified Blood Glucose Control Algorithm

You are being asked to take part in this research study because you have type 1 diabetes. The purpose of this study is to evaluate an experimental device called the Medtronic external Physiologic Insulin Delivery (ePID) system.  The ePID system uses periodic measurements from a subcutaneous (under the skin) glucose (sugar) sensor, an algorithm (calculation) to determine when the pump should deliver insulin.  The study will also compare two algorithms.  Your participation in this study will be for a maximum of six months including a screening visit of approximately 2 hours, two three-day outpatient Continuous Glucose Monitoring System (CGMS) study, and two inpatient ePID (closed-loop) study over 2 days and 2 nights (approximately 44 hours)

Patient Inclusion/Exclusion Criteria:

- See http://clinicaltrials.coh.org for additional information.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: August 4, 2008 at 1:56:47 PM